Humanalbumin, Hydroxyethylstarch and Ringer Lactate During Cardiac Surgery
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The aim of the study is to compare three different regimens for volume replacement during
cardiac surgery, e.g. Albumin 5%, Hydroxyethylstarch 130/0.4 (HES) and Ringer-Lactate (RL).
Main Outcome parameters: chest tube drainage and coagulation parameters. The investigators
hypothesis is that HES is as safe as Albumin, however less expensive. Whether RL is an even
less expensive and as safe alternative has to be shown.